Tarsus Pharmaceuticals (TARS)
Quick facts
| Ticker | TARS (NASDAQ) |
|---|
Marketed products
- Xdemvy · Other
Xdemvy works by targeting and killing Demodex mites that cause blepharitis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Tarsus Pharmaceuticals
What is the ticker symbol for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals trades as TARS on the NASDAQ.
What are Tarsus Pharmaceuticals's marketed drugs?
Top marketed products include Xdemvy.
How many employees does Tarsus Pharmaceuticals have?
Tarsus Pharmaceuticals has approximately 370 employees.
Related
- Xdemvy · Other
- Sector hub: All tracked pharma companies
- Ticker: TARS · NASDAQ